STAT Plus: Pharmalittle: Roche says its drug helped Covid-19 patients; Trump expected to finalize drug importation plan
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is rather modest. We hope to catch up on our reading, hang with a short person or two, and promenade with the official mascot. And what about you? This is a fine time to enjoy the great outdoors. You could arrange for a mail-in ballot for the upcoming election. Or you could reach out to someone feeling isolated these days. Well, whatever you do, have a grand time. But be safe — wear a mask. Enjoy, and see you soon. …
Roche (RHHBY) reported that its Actemra drug reduces the likelihood patients with Covid-19-related pneumonia need mechanical ventilation, Pharmaphorum reports. Hospitalized patients taking the drug were 44% less likely to need ventilators or die, citing the results of a Phase 3 study, which is the first global Phase 3 Covid-19 clinical trial to primarily enroll patients from underrepresented racial and ethnic groups. There was no statistically significant improvement in reducing mortality alone, however.
Continue to STAT Plus to read the full story…
